Main

Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLCGreenleaf


Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLC
Greenleaf Health LLC today announced that Michael Chappell, former Acting Associate Commissioner for Regulatory Affairs at the Food and Drug Administration , has joined the firm as Senior Advisor.

Hybrid Fuels, Inc. Announces FDA Approved Lab Selection for Azul Instant - "Be Ready in an Instant"
FORT LAUDERDALE, Fla., Feb. 2, 2012 /PRNewswire/ -- Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today that after a lengthy and heavily scrutinized review process that it has selected a state-of-the-art ...

FDA is Placing More Brazilian Orange Juice Companies on Import Alert, According to FDAImports.com
The U.S. Food and Drug Administration is placing more Brazilian orange juice companies on Import Alert for the presence of Carbendazim/MBC, according to Benjamin England and FDA consulting firm, FDAImports.com.Columbia, MD (PRWEB) February 02, 2012 The U.S. Food and Drug Administration is placing more Brazilian orange juice companies on Import Alert for the presence of Carbendazim/MBC, according ...

FDA Tells Weight-Loss Surgery Centers To Pull Misleading AdsThe Food


FDA Tells Weight-Loss Surgery Centers To Pull Misleading Ads
The Food and Drug Administration has warned a marketing company and eight surgery centers in Southern California that their marketing of weight-loss surgery is misleading. Ads touted the benefits without adequately describing the risks.

FDA faults Invacare s compliance: Production at Elyria headquarters could be suspended due to regulations
ELYRIA Production at Invacare s Elyria headquarters could be suspended pending compliance with Food and Drug Administration regulations, according to Invacare spokeswoman Lara Mahoney.

FDA Warns Consumers About ShoulderFlex Massager
Title: FDA Warns Consumers About ShoulderFlex Massager Category: Health News Created: 12/22/2011 11:01:00 AM Last Editorial Review: 12/22/2011
 
Notify me with the latest breaking FDA News
fda approvals Tell us where to send your notifications:

FDA faults Invacare s compliance: Production at Elyria headquarters could be


FDA faults Invacare s compliance: Production at Elyria headquarters could be suspended due to regulations
ELYRIA Production at Invacare s Elyria headquarters could be suspended pending compliance with Food and Drug Administration regulations, according to Invacare spokeswoman Lara Mahoney.

FDA Tells Weight-Loss Surgery Centers To Pull Misleading Ads
The Food and Drug Administration has warned a marketing company and eight surgery centers in Southern California that their marketing of weight-loss surgery is misleading. Ads touted the benefits without adequately describing the risks.

 

©2006 FDA-News.com. All rights reserved.